SCHEMBL1722672

SCHEMBL1722672

CCSc1nc2cc(C(F)(F)F)ccc2c(C)c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.40
CTSD P07339 2/20 0.37
BACE1 P56817 1/20 0.36
ATP4A P20648 1/20 0.35
ATP4B P51164 1/20 0.35
EPHX2 P34913 1/20 0.35
SCN4A P35499 1/20 0.35
KDM4E B2RXH2 2/20 0.34
PSMD14 O00487 1/20 0.34
USP2 O75604 1/20 0.34
ILK Q13418 1/20 0.34
ALDH1A1 P00352 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
DDR1 Q08345 1/20 0.33
F7 P08709 1/20 0.33
F3 P13726 1/20 0.33
KCNH2 Q12809 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
PKM P14618 1/20 0.33
PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3089755 0.82 CYP1A2 (0.38) PDE10AKDM4EPSMD14USP2
SCHEMBL1721616 0.80 DHODH (0.46) PDE10AKDM4EALDH1A1
SCHEMBL1721617 0.77 PTGDR2 (0.38) PDE10AKDM4EUSP2ALDH1A1
Ammonia Solution, Strong SCHEMBL3496901 0.75 CTSD (0.40) PDE10ACTSDBACE1EPHX2SCN4A
SCHEMBL1722658 0.75 ALDH1A1 (0.45) ALDH1A1
SCHEMBL1723192 0.74 PTGFR (0.40) PDE10ADDR1
SCHEMBL1721222 0.73 SORT1 (0.43) EPHX2KDM4EPSMD14L3MBTL1
SCHEMBL1721705 0.73 MRGPRX4 (0.38) ALDH1A1
SCHEMBL1721493 0.73 MLYCD (0.39) ALDH1A1
SCHEMBL1723330 0.73 USP2 (0.42) KDM4EUSP2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406228-B1 Substituted 3-amino-2-mercaptochinolins as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-09-18 EP disclosed
US-8207342-B2 Substituted 3-amino-2-mercaptoquinolines as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2012-06-26 US disclosed
EP-2406228-A1 SUBSTITUTED 3-AMINO-2-MERCAPTOQUINOLINES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2012-01-18 EP disclosed
WO-2010102779-A1 SUBSTITUTED 3-AMINO-2-MERCAPTOQUINOLINES AS KCNQ2/3 MODULATORS Grünenthal GmbH (DE) 2010-09-16 WO disclosed
US-20100234421-A1 SUBSTITUTED 3-AMINO-2-MERCAPTOQUINOLINES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234421-A1 SUBSTITUTED 3-AMINO-2-MERCAPTOQUINOLINES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNQ3 PDE10A 2750/4885CTSD 4670/4885BACE1 4188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.